Mike J. Baxter
Singleton Park
Swansea, WLS SA28PP, United Kingdom
Swansea, WLS SA28PP, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A Systematic Literature Review of Psychological Interventions for Adults with Type 1 Diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: September 25, 2023
Simultaneous Versus Sequential Initiation of Lixisenatide and Basal Insulin for Type 2 Diabetes: Subgroup Analysis of a Japanese Post-Marketing Surveillance Study of Lixisenatide (PRANDIAL).
Journal: Advances in therapy
Published: June 14, 2022
Brief Digital Solutions in Behavior Change Interventions for Type 2 Diabetes Mellitus: A Literature Review.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 27, 2021
Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 04, 2021
Benefit of insulin glargine/lixisenatide for reducing residual hyperglycaemia in Japan: Post hoc analysis of the LixiLan JP-O2 trial.
Journal: Diabetes, obesity & metabolism
Published: May 31, 2021
A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 05, 2021
Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people.
Journal: Aging clinical and experimental research
Published: January 21, 2021
iGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post-hoc analysis of the LixiLan JP-L trial.
Journal: Journal of diabetes investigation
Published: August 05, 2020
Benefits of the fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide (iGlarLixi) in Japanese people with type 2 diabetes: A subgroup and time-to-control analysis of the LixiLan JP phase 3 trials.
Journal: Diabetes, obesity & metabolism
Published: May 01, 2020
A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 17, 2020
Fixed-ratio combination of basal insulin and glucagon-like peptide-1 receptor agonists in the treatment of Japanese people with type 2 diabetes: An innovative solution to a complex therapeutic challenge.
Journal: Diabetes, obesity & metabolism
Published: February 28, 2020
A review of the NG17 recommendations for the use of basal insulin in type 1 diabetes.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: November 11, 2019
Last Updated: 09/26/2026